Annual Cash & Cash Equivalents
$50.91 M
-$5.13 M-9.16%
December 31, 2022
Summary
- As of February 9, 2025, SURF annual cash & cash equivalents is $50.91 million, with the most recent change of -$5.13 million (-9.16%) on December 31, 2022.
- During the last 3 years, SURF annual cash & cash equivalents has risen by +$4.16 million (+8.89%).
Performance
SURF Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$14.84 M
-$14.14 M-48.79%
June 30, 2023
Summary
- As of February 9, 2025, SURF quarterly cash and cash equivalents is $14.84 million, with the most recent change of -$14.14 million (-48.79%) on June 30, 2023.
- Over the past year, SURF quarterly cash and cash equivalents has dropped by -$59.98 million (-80.16%).
Performance
SURF Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SURF Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.2% | -80.2% |
| 3 y3 years | +8.9% | -84.1% |
| 5 y5 years | +126.7% | -70.8% |
SURF Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.2% | at low | -80.2% | at low |
| 5 y | 5-year | -70.9% | -8.2% | -91.5% | at low |
| alltime | all time | -70.9% | -80.4% | -91.5% | at low |
Surface Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $14.84 M(-48.8%) |
| Mar 2023 | - | $28.98 M(-43.1%) |
| Dec 2022 | $50.91 M(-9.2%) | $50.91 M(-21.8%) |
| Sep 2022 | - | $65.10 M(-13.0%) |
| Jun 2022 | - | $74.82 M(+14.0%) |
| Mar 2022 | - | $65.66 M(+17.2%) |
| Dec 2021 | $56.05 M(-68.0%) | $56.05 M(-7.9%) |
| Sep 2021 | - | $60.85 M(-27.0%) |
| Jun 2021 | - | $83.33 M(-17.1%) |
| Mar 2021 | - | $100.53 M(-42.6%) |
| Dec 2020 | $175.14 M | $175.14 M(+76.1%) |
| Sep 2020 | - | $99.47 M(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $93.13 M(+65.1%) |
| Mar 2020 | - | $56.42 M(+20.7%) |
| Dec 2019 | $46.76 M(-43.6%) | $46.76 M(+21.4%) |
| Sep 2019 | - | $38.52 M(+2.0%) |
| Jun 2019 | - | $37.75 M(-8.6%) |
| Mar 2019 | - | $41.31 M(-50.2%) |
| Dec 2018 | $82.91 M(+269.2%) | $82.91 M(+99.3%) |
| Sep 2018 | - | $41.59 M(-18.1%) |
| Jun 2018 | - | $50.77 M(-14.4%) |
| Mar 2018 | - | $59.29 M(+164.0%) |
| Dec 2017 | $22.45 M(+124.7%) | $22.45 M |
| Dec 2016 | $9.99 M | - |
FAQ
- What is Surface Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Surface Oncology?
- What is Surface Oncology annual cash & cash equivalents year-on-year change?
- What is Surface Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Surface Oncology?
- What is Surface Oncology quarterly cash and cash equivalents year-on-year change?
What is Surface Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of SURF is $50.91 M
What is the all time high annual cash & cash equivalents for Surface Oncology?
Surface Oncology all-time high annual cash & cash equivalents is $175.14 M
What is Surface Oncology annual cash & cash equivalents year-on-year change?
Over the past year, SURF annual cash & cash equivalents has changed by -$5.13 M (-9.16%)
What is Surface Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SURF is $14.84 M
What is the all time high quarterly cash and cash equivalents for Surface Oncology?
Surface Oncology all-time high quarterly cash and cash equivalents is $175.14 M
What is Surface Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, SURF quarterly cash and cash equivalents has changed by -$59.98 M (-80.16%)